Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$459.92
$459.06
$274.98
$503.24
$809.46M0.6923,283 shsN/A
Haemonetics Co. stock logo
HAE
Haemonetics
$70.23
+3.0%
$62.75
$55.30
$97.97
$3.53B0.32695,591 shs845,715 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$144.34
+4.4%
$140.68
$100.91
$196.26
$3.55B0.87275,107 shs366,510 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$98.73
+3.0%
$97.00
$80.02
$111.45
$5.83B0.7513,606 shs963,236 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%0.00%0.00%0.00%+3.27%
Haemonetics Co. stock logo
HAE
Haemonetics
0.00%+6.68%+13.75%+12.73%-28.84%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%-2.36%-3.05%-13.44%+29.13%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.00%+0.18%+4.12%-12.82%+18.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/AN/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
4.0758 of 5 stars
3.42.00.04.32.21.71.3
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.5494 of 5 stars
3.53.00.03.93.11.71.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.64 of 5 stars
2.51.00.03.83.12.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
0.00
N/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
2.78
Moderate Buy$97.8939.38% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$192.6733.48% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.00
Buy$107.789.16% Upside

Current Analyst Ratings Breakdown

Latest ICUI, HAE, MMSI, and ATRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Haemonetics Co. stock logo
HAE
Haemonetics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy$115.00 ➝ $105.00
5/9/2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetStrong-Buy ➝ Strong-Buy$197.00 ➝ $187.00
5/8/2025
Haemonetics Co. stock logo
HAE
Haemonetics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $84.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$106.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$127.00 ➝ $108.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$116.00 ➝ $108.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$116.00 ➝ $100.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$111.00 ➝ $103.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$111.00 ➝ $110.00
4/23/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$116.00 ➝ $112.00
4/21/2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$209.00 ➝ $191.00
(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$181.60M4.46$19.68 per share23.37$138.02 per share3.33
Haemonetics Co. stock logo
HAE
Haemonetics
$1.36B2.59$6.70 per share10.48$18.05 per share3.89
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.38B1.49$13.54 per share10.66$87.96 per share1.64
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.39B4.20$4.51 per share21.89$20.81 per share4.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$10.6443.23N/A10.60%7.75%7.12%N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$117.56M$3.3127.6513.931.119.47%23.66%8.82%N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$3.83N/A26.53N/A-4.74%5.05%2.42%N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$94.41M$2.0448.4026.332.349.05%15.61%8.38%N/A

Latest ICUI, HAE, MMSI, and ATRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
Haemonetics Co. stock logo
HAE
Haemonetics
$1.22$1.24+$0.02$1.17$329.38 million$330.60 million
5/8/2025Q1 2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.23$1.72+$0.49-$0.63$574.15 million$599.49 million
4/24/2025Q1 2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.75$0.86+$0.11$0.49$352.57 million$355.35 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.801.91%+9.65%82.71%21 Years
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.18
3.06
Haemonetics Co. stock logo
HAE
Haemonetics
1.35
3.97
2.55
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.75
2.29
1.03
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.57
5.36
3.82

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Haemonetics Co. stock logo
HAE
Haemonetics
1.80%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
1.50%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7201.76 million1.36 millionNot Optionable
Haemonetics Co. stock logo
HAE
Haemonetics
2,82050.24 million49.33 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,50024.61 million22.84 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
6,85059.10 million56.12 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atrion stock logo

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Haemonetics stock logo

Haemonetics NYSE:HAE

$70.23 +2.04 (+2.99%)
Closing price 03:59 PM Eastern
Extended Trading
$69.30 -0.93 (-1.33%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$144.34 +6.04 (+4.37%)
Closing price 04:00 PM Eastern
Extended Trading
$144.48 +0.13 (+0.09%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$98.73 +2.90 (+3.03%)
Closing price 04:00 PM Eastern
Extended Trading
$98.75 +0.02 (+0.02%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.